Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

por Louis, Edouard J., Reinisch, Walter, Schwartz, David A., Löfberg, Robert, Robinson, Anne M., Berg, Sofie, Wang, Anthony W., Maa, Jen-fue, Huang, Bidan, Pappalardo, Brandee
Publicado 2018

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA

por Travis, Simon, Feagan, Brian G, Peyrin-Biroulet, Laurent, Panaccione, Remo, Danese, Silvio, Lazar, Andreas, Robinson, Anne M, Petersson, Joel, Pappalardo, Brandee L, Bereswill, Mareike, Chen, Naijun, Wang, Song, Skup, Martha, Thakkar, Roopal B, Chao, Jingdong
Publicado 2017